Herb - Drug interaction of noni juice and Ginkgo biloba with phenytoin

Pharmacognosy Journal

Volumn 2, Issue 18, 2011, Pages 33-41

  Chandra, Rodda Harish ^a   Veeresham, Ciddi ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Epilepsy; G.biloba; Herb Drug interactions; Noni juice; Phenytoin; CYP2C9

Indexed keywords

CELL MARKER; CYTOCHROME P450 2C9; FLUCONAZOLE; GINKGO BILOBA EXTRACT; PHENYTOIN; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; ENZYME INDUCTION; ENZYME INHIBITION; GINKGO BILOBA; HUMAN; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 84856963749     PISSN: 09753575     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0975-3575(11)80023-4     Document Type: Article

References (62)

1. McClatchey W. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integr Cancer Ther. 2002;1:110-20. (Pubitemid 36834917)
2. Wang MY, West BJ, Jensen CT, Nowicki D, Su C, Palu AK, et al. Morinda citrifolia (Noni): A literature review and recent advances in Noni Research. Acta Pharmacol Sin. 2002;23:1127-41. (Pubitemid 35470338)
3. Saludes JP, Gordon MJ, Franz BSG, Aguinaldo AM. Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn (Rubiaceae). Phytother Res. 2002;16:683-5. (Pubitemid 35339399)
4. Ancolio C, Azas N, Mahiou V, Ollivier E, Di Giorgio C, Keita A et al. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother Res. 2002;16:646-9. (Pubitemid 35334185)
5. Umezawa K, Imoto M, Ooba S, Koyano T, Komyama Y. Isolation of 1-methoxy-2-foremyl-3-hydroxyanthraquinone from Morinda citrifolia and neoplasmin inhibitors containing the same. JP 06, 87, 736, April 1992.
6. Anne H, Eiichi F. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with anti tumour activity. Phytother Res. 1999;13:380-7.
7. Kamiya K, Tanaka Y, Endang H, Umar M, Satake T. Chemical constituents of Morinda citrifolia fruits inhibit copper induced low - density lipoprotein oxidation. J Agric Food Chem. 1999;52:5843-8.
8. Shotipruk A, Kiatsongserm J, Pavasant P, Goto M, Sasaki M. Pressurized hot water extraction of anthraquinones from the roots of Morinda citrifolia. Biotechnol Prog. 2004;20:1872-5. (Pubitemid 39606475)
9. De Feudis FV, Drieu K. Ginkgo biloba Extract (EGb 761) and CNS functions - basic studies and clinical applications. Curr Drug Targets. 2000;1:25-58.
10. Drieu K. Preparation and definition of Ginkgo biloba extract. Presse Med. 1986;25:1455-7. (Pubitemid 16018103)
11. Nasr C, Haag-Berurrier M, Lobstein-Guth A, Anton R. Kaempferol coumraoyl glucorhamnoside from Ginkgo biloba. Phytochem. 1986;25:770-1.
12. Nasr C, Haag-Berurrier M, Lobstein-Guth A, Anton R. Quercetin coumaryl glucorhamnoside from Ginkgo biloba. Phytochem. 1987;26:2869-70.
13. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340:1136-9.
14. Stromgaard K, Nakanishi K. Chemistry and biology of terpene trilactones from Ginkgo biloba. Angew Chem Int Ed Engl. 2004;43:1640-58. (Pubitemid 39257855)
15. Bridi R, Crossetti F P, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res. 2001;15:449-451. (Pubitemid 32762399)
16. Juguet F, Drieu K, Piriou A. Decreased cerebral 5-HT1A receptors during aging: reversal by Ginkgo biloba Extract. J Pharm Pharmacol. 1994;46:316-8.
17. Vorberg. G. "Ginkgo biloba Extract (GBE): A Long-Term Study of Chronic Cerebral Insufficiency in Geriatric Patients." Clinical Trials J. 1985;22:149-57. (Pubitemid 15097813)
18. Uríkova A., Babusikoa E, Dobrota D, Drgova A, Kaplan P, Tatarkova Z, et al. Impact of Ginkgo Biloba Extract EGb 761 on Ischemia/Reperfusion - Induced Oxidative Stress Products Formation in Rat Forebrain. Cell Mol Neurobiol. 2006;26:1341-51.
19. Loffier T, Lee SK, Noldner M, Chatterjee SS, Hoyer S, Schliebs R. Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain. J Neural Transm. 2001;108:1457-74. (Pubitemid 34020449)
20. Jean H, Robert H. Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761. Wien Med Wochenschr. 2004;154:511-14.
21. Christen Y. Ginkgo biloba and neurodegenerative disorders. Front Biosci. 2004;9:3091-104.
22. Xiang YZ, Dong FZ, Lian YC, Gui YW. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacol. 2006;188:12-7.
23. Patil NP. Ginkgo biloba extract (GBE) and the vestibular system. A craniocorpographic and electronystagmographic assessment. Ind J Otolaryng Head Neck Surg. 1989;41:59-60.
24. Hoffmann F, Beck C, Schutz A, Offermann P. Ginkgo Extract EGb 761 (tenobin)/HAES versus niftidrofuryl (Dusodril) Haes. A Randomised study of therapy of sudden deafness" Laryngorhinootologie. 1994;73:149-52. (Pubitemid 24091289)
25. Papadopoulos V, Kapsis A, Li H, Amri H, Hardwick M, Culty M et al, Druginduced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res. 2000;20:2835-47.
26. Su Y, Sun CM, Chuang HH, Chang PT. Studies on the cytotoxic mechanisms of ginketin in a human ovarian adenocarcinoma cell line. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:82-90.
27. Agha AM, El-Fattah AA, Al-Zuhair HH, Al-Rikabi AC. Chemopreventive effect of Ginkgo biloba extract against benzo (a) pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity. J. Exp. Clin. Cancer Res. 2001;20:39-50. (Pubitemid 32423972)
28. Chao JC, Chu CC. Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J Gastroenterol. 2004;10:37-41. (Pubitemid 38071974)
29. Suzuki R, Kohno H, Sugie S. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethaneinduced colonic aberrant crypt foci in rats. Cancer Lett. 2004;210:159-69. (Pubitemid 38748686)
30. Kim KS, Rhee KH, Yoon JH, Lee JG, Lee, JH, Yoo JB. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol. 2005;41:383-9. (Pubitemid 40387867)
31. Ye B, Aponte M, Dai Y, Li L, Ho MC, Vitonis A, et al. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Lett. 2007;251:43-52. (Pubitemid 46613833)
32. Oh SM, Kim HR, Chung KH. Effects of Ginkgo biloba on in vitro osteoclast cells and ovariectomised rat osteoblast cells. Arch Pharm Res. 2008;31:216-24
33. Marlangue CC, Zouaoui DA, Represa A, Ari, YB. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp I20 toxicity. Trends neurosci. 1996;19:109-14.
34. Halliwel B. Role of free radicals in neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drug Aging. 2001;18:685-716.
35. Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Intl J Neurosci. 1991;57:1-17.
36. Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev. 1997;25:335-58. (Pubitemid 28071452)
37. Kurekni AE, Alpay F, Tanindi S, G'Oknay E, Ozcan O, Akin R, et al. Plasma trace elements, plasma glutathione peroxidase and superoxide dismutase levels in epileptic children receiving AEDs therapy. Epilepsia. 1995;36:600-4.
38. Maertens P, Dyken P, Graf W, Pippenger C, Chronister R, Sha A. Free radicals, anticonvulsants and the neuronal ceroid lipofuscinosis. Amer J Med Gen. 1995;57:225-8.
39. Parman T, Chen G, Wells PG. Free radical intermediates of phenytoin and related teratogens. J Bio Chem. 1995;273:25079-88.
40. Gerber N, Diekinson RG, Harland RC, Lynn RK, Houghcon LD, Antonias JI, et al. Reye-like syndrome associated with valproic acid therapy. J Pedia. 1979;95:142-4. (Pubitemid 9183702)
41. Kuo CC, Chen RS, Lu L, Chen RC. Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol Pharmacol. 1997;51:1077-83. (Pubitemid 27249142)
42. Liu CS, Wu HM, Kao SH, Wei YH. Phenytoin-mediated oxidative stress in serum female epileptics: A possible pathogenesis in the fetal hydantoin syndrome. Hum Exp Toxicol. 1997;16:177-81
43. http://www.noniisgoodforyou.com/industry.asp.
44. He-Ping L, Wei J, Jian L, Hao C, Zhi-Rong T, Dong-Li H, Li-Juan L, Hong-Hao Z. Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers. Br J Clin Pharmacol. 2009;68:201-6.
45. Kishore P, Rajnarayana K, Reddy MS, Vidyasagar J, Krishna DR. Validated HPLC method for simultaneous determination of phenytoin, phenobarbitone and carbamazepine in Human serum and its application in pharmacokinetic studies. Drug Res. 2003;53:763-8. (Pubitemid 37463920)
46. Raju J. A novel drug targeting approach using antioxidant surface loaded colloidal carriers. PhD. Thesis, University College of Pharmaceutical Sciences, Kakatiya University, Andhra Pradesh, India, 2008.
47. Reddy YN, Murthy SV, Krishna DR, Prabhakar MC. Role of free radicals and antioxidants in tuberculosis patients. Indian J Tuberc. 2004;51:213-8. (Pubitemid 39470928)
48. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by Thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358. (Pubitemid 9194347)
49. Cuttle L, Munns A J. Hogg NA, Scott JR, Hooper WD, Dickinson RG, Gillam EMJ. Phenytoin Metabolism by Human Cytochrome P450: Involvement of P450 3A and 2C Forms in Secondary Metabolism and Drug-Protein Adduct Formation. Drug Metab Dispos. 2000;28:945-50. (Pubitemid 30612614)
50. Weiss J, Kerpen C J, Lindenmaier H, Dormann SG and Haefeli WE. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther. 2003;307:262-7. (Pubitemid 37151916)
51. Fujita K. Food-drug interactions via human cytochrome P450 3A (CYP3A). Drug Metabol Drug Interact. 2004;20:195-217. (Pubitemid 40083055)
52. Jingling T, Jin S, Yongqiang Z, Lin L, Fude C, Zhonggui H. Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats. Food Chem Toxicol. 2007;45:2441-5.
53. Li ZZ, Ming H, Jie C, Pui LRE, Eli C, Wei D, Yong-Yuna G, Yun-Han H, Xiao C, and Shufeng Z. Induction of Propranolol Metabolism by Ginkgo biloba Extract EGb 761 in Rats. Curr Drug Metab. 2006;7:577-87.
54. Kubota Y, Kobayashi K, Tanaka N, Nakamura K, Kunitomo M, Umegaki K, Shinozuka K. Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats. J Pharm Pharmacol. 2004;56, 401-5. (Pubitemid 38380224)
55. Shinozuka K, Umegaki K, Kubota Y, Tanaka N, Mizuno H, Yamauchi J, Nakamura K, Kunitomo M. Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci. 2002;70:2783-92. (Pubitemid 34312011)
56. Yoshioka M, Ohnishi N, Sone N, Egami S, Takara K, Yokoyama T, Kuroda K. Studies on Interactions between Functional Foods or Dietary Supplements and Medicines. III. Effects of Ginkgo biloba Leaf Extract on the Pharmacokinetics of Nifedipine in Rats. Biol Pharm Bull. 2004;27:2042-5. (Pubitemid 41701588)
57. Sugiyama T, Kubota Y, Shinozuka K, Yamada S, Wu J, Umegaki K. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats. Life Sci. 2004;75:1113-22. (Pubitemid 38780993)
58. Umegaki K, Saito K, Kubota Y, Sanada H, Yamada K, Shinozuka K: Ginkgo biloba extract markedly induces pentoxyresorufin O - dealkylase activity in rats. Jpn J Pharmacol. 2002;90:345-51. (Pubitemid 36096890)
59. Gaudineau C, Beckerman R, Welbourn S, Auclair K. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Biophys Res Commun. 2004;318:1072-8. (Pubitemid 38625885)
60. He N, Edeki T. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther. 2004;11:206-12.
61. *1 genotype. Can J of Physiol Pharmacol. 2007;85:848-55. (Pubitemid 350189726)
62. Laura LBP, Susan KS. Ginkgo biloba extract: Review of CNS effects. Ann Clin Psychiat. 2003;15:109-19